[HTML][HTML] Диагностика и лечение тромбоэмболии лёгочной артерии: клинические рекомендации Евразийской ассоциации кардиологов для практических …

ЕП Панченко, ТВ Балахонова… - Евразийский …, 2021 - cyberleninka.ru
Отказ от ответственности. Рекомендации ЕАК отражают точку зрения ЕАК и были
подготовлены после тщательного изучения научных и медицинских данных …

Indefinite anticoagulant therapy for first unprovoked venous thromboembolism: a cost-effectiveness study

F Khan, D Coyle, K Thavorn, S van Katwyk… - Annals of internal …, 2023 - acpjournals.org
Background: Clinical practice guidelines recommend indefinite anticoagulation for a first
unprovoked venous thromboembolism (VTE). Objective: To estimate the benefit–harm …

D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study

G Palareti, D Poli, W Ageno, C Legnani… - Blood …, 2022 - ashpublications.org
D-dimer assay is used to stratify patients with unprovoked venous thromboembolism (VTE)
for the risk of recurrence. However, this approach was never evaluated since direct oral …

[HTML][HTML] Direct oral anticoagulants after bariatric surgery—what is the evidence?

R Leong, DK Chu, MA Crowther… - Journal of Thrombosis and …, 2022 - Elsevier
Background Obesity is a global epidemic and bariatric surgery is used with increasing
frequency to treat its complications. The extent to which bariatric surgery alters the efficacy …

[HTML][HTML] Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the Russian Association of Gerontologists and Geriatricians and the …

ON Tkacheva, NM Vorobyeva… - Cardiovascular …, 2021 - cardiovascular.elpub.ru
Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the
Russian Association of Gerontologists and Geriatricians and the National Society of Preventive …

[HTML][HTML] Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis

L Vasanthamohan, K Boonyawat… - Journal of Thrombosis …, 2018 - Elsevier
Essentials• In venous thromboembolism (VTE), benefits of extended treatment are balanced
by bleeding risks.• This is a meta‐analysis of reduced‐dose direct oral anticoagulants …

[HTML][HTML] Anticoagulant‐associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants

Y Xu, DM Siegal - Journal of Thrombosis and Haemostasis, 2021 - Elsevier
Gastrointestinal (GI) bleeding is the most frequent single site of oral anticoagulant (OAC)‐
associated major bleeding. Patients with major GI bleeding experience morbidity and a …

Venous thromboembolism in multiple myeloma–choice of prophylaxis, role of direct oral anticoagulants and special considerations

D Swan, A Rocci, C Bradbury… - British Journal of …, 2018 - Wiley Online Library
Multiple myeloma is associated with a significant risk of venous thromboembolism (VTE),
causing substantial levels of morbidity and mortality. The thrombogenicity of myeloma is …

Bleeding in patients with gastrointestinal cancer compared with nongastrointestinal cancer treated with apixaban, rivaroxaban, or enoxaparin for acute venous …

DE Houghton, DT Vlazny, AI Casanegra… - Mayo Clinic …, 2021 - Elsevier
Objective To compare the bleeding risk in patients with gastrointestinal (GI) cancer with that
in patients with non-GI cancer treated with anticoagulation for acute cancer-associated …

Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials

T Wu, C Lv, L Wu, W Chen, M Lv, S Jiang, J Zhang - Journal of neurology, 2022 - Springer
Objective We performed a systematic review and meta-analysis to compare the risk of
intracranial hemorrhage (ICH) between direct oral anticoagulants (DOACs) and other …